Showing results (251-260 of 346) with videos related to

Sort By:
Pageof 35
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthmaMitesh Patel, Janine Pilcher, Helen K Reddel, et al.
Respirology (Carlton, Vic.)|July 21, 2022
Treatable traits in the NOVELTY studyAlvar Agustí, Eleni Rapsomaniki, Richard Beasley, et al.
The New Zealand Medical Journal|March 2, 2021
New Zealand COPD Guidelines: Quick Reference GuideRobert J Hancox, Stuart Jones, Christina Baggott, et al.
Intensive Care Medicine|February 1, 2012
Early peak temperature and mortality in critically ill patients with or without infectionPaul Jeffrey Young, Manoj Saxena, Richard Beasley, et al.
NPJ Primary Care Respiratory Medicine|January 9, 2015
The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysisMitesh Patel, Janine Pilcher, Robert J Hancox, et al.
Respirology (Carlton, Vic.)|November 13, 2024
Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statementDanielle F Wurzel, Brett D Montgomery, Natalie Anderson, et al.
Respiratory Care|February 18, 2025
Efficacy of Noninvasive Ventilation With Expiratory Washout in Stable COPD PatientsStacey Kung, Alex C Semprini, Louis W Kirton, et al.
Respirology (Carlton, Vic.)|September 3, 2016
Target oxygen saturation range: 92-96% Versus 94-98Richard Beasley, Jimmy Chien, James Douglas, et al.
Plos One|October 27, 2010
Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemicDon Bandaranayake, Q Sue Huang, Ange Bissielo, et al.
BMC Pulmonary Medicine|May 9, 2020
The effect of 50% oxygen on PtCO2 in patients with stable COPD, bronchiectasis, and neuromuscular disease or kyphoscoliosis: randomised cross-over trialsJanine Pilcher, Darmiga Thayabaran, Stefan Ebmeier, et al.
Pageof 35